Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
SchizophreniaDiabetesInsulin Resistance
Interventions
PROCEDURE

Glucose clamp technique

euglycemic hyperinsulinemic clamp with target blood glucose of 90 mg/dl (5 mmol/l), followed by hyperglycemic clamp, target blood glucose of 180 mg/dl (10 mmol/l) for measurement of insulin sensitivity and insulin secretion

DRUG

Amisulpride

Single dose of amisulpride 200 mg p.o. given at 8:00 a.m.

DRUG

Olanzapine

Single dose of olanzapine 10 mg p.o. given at 8:00 a.m.

DRUG

Placebo

Placebo capsules are given at 8:00 a.m.

Trial Locations (1)

68159

Central Institute of Mental Health, Mannheim

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Central Institute of Mental Health, Mannheim

OTHER